# Dung T. Le

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/dung-t-le/

## Facts

| Field | Value |
| --- | --- |
| Citations | 50,202 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 67 |
| i10-index | 160 |
| Last Known Institution | Bloomberg (United States) |
| OpenAlex ID | https://openalex.org/A5011776853 |
| ORCID iD | https://orcid.org/0000-0002-2110-7697 |
| Works | 514 |

## Researcher papers

- [PD-1 Blockade in Tumors with Mismatch-Repair Deficiency](https://scholariq.org/papers/pd-1-blockade-in-tumors-with-mismatch-repair-deficiency/)
- [Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade](https://scholariq.org/papers/mismatch-repair-deficiency-predicts-response-of-solid-tumors-to-pd-1-blockade/)
- [Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies](https://scholariq.org/papers/detection-of-circulating-tumor-dna-in-early-and-late-stage-human-malignancies/)
- [Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors](https://scholariq.org/papers/clinicopathological-features-of-acute-kidney-injury-associated-with-immune/)
- [Safety and Survival With GVAX Pancreas Prime and <i>Listeria Monocytogenes</i>–Expressing Mesothelin (CRS-207) Boost Vaccines for Metastatic Pancreatic Cancer](https://scholariq.org/papers/safety-and-survival-with-gvax-pancreas-prime-and-i-listeria-monocytogenes-i/)
- [A Lethally Irradiated Allogeneic Granulocyte-Macrophage Colony Stimulating Factor-Secreting Tumor Vaccine for Pancreatic Adenocarcinoma](https://scholariq.org/papers/a-lethally-irradiated-allogeneic-granulocyte-macrophage-colony-stimulating/)
- [A Live-Attenuated Listeria Vaccine (ANZ-100) and a Live-Attenuated Listeria Vaccine Expressing Mesothelin (CRS-207) for Advanced Cancers: Phase I Studies of Safety and Immune Induction](https://scholariq.org/papers/a-live-attenuated-listeria-vaccine-anz-100-and-a-live-attenuated-listeria/)
- [Mesothelin Immunotherapy for Cancer: Ready for Prime Time?](https://scholariq.org/papers/mesothelin-immunotherapy-for-cancer-ready-for-prime-time/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Genetic factors in colorectal cancer](https://scholariq.org/topics/genetic-factors-in-colorectal-cancer/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

## Researcher university

- [Bloomberg (United States)](https://scholariq.org/institutions/bloomberg-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.